-Board member, providing experienced and mature oversight to UK FTSE-listed subsidiary and a Chinese healthcare company expanding into SEA. -Consulting & Advisory: e.g. for a client targeting an industrial peer for acquisition, i.e. potential synergies, value of such synergies, operational challenges in the Asia Pacific region -start-ups in Singapore, i.e. their launch plans and investment pack (have worked with start-ups from NUS Enterprise & SUTD) -provided advice on strategic pivots for companies, e.g. advisory to owners as they negotiations with partners, + SIM exit from Entrepreneurship sector,

-Updated strategy for Greater China countries-drove new M&A initiatives in line with new strategy-put in place new operational initiatives

-led the full value chain (R&D, 2 Mfg facilities, Commercial and Operations, incl. Regulatory, Medical and Govt. Affairs) - led the preparation of dossiers for our 2 in-house biosimilars for CFDA reviews- put in place vigorous operational systems resulting in flagship product out-performing peers -completed a alliance with Chinese conglomerate

-Led expansion of Sales Force -2 flagship products became market leaders

- built SE Asia Team after company restructuring- grew 2x GDP growth rate 2003-2008- became most profitable region in Asia Pacific

- launched Celebrex and Xalatan in Singapore, Malaysia and Indonesia- completed restructuring in Singapore- involved in 2 M&A integration initiatives

- set up Monsanto office in Vietnam (start-up)- became fastest growing and 2nd major agronomy company in Vietnam by 1999- Localized GM position with internal manager.